Neurodevelopmental Outcomes after Premedication with Atropine/Propofol vs Atropine/Atracurium/Sufentanil for Neonatal Intubation: 2-Year Follow-Up of a Randomized Clinical Trial
This study followed 173 newborn infants in the PREmedication Trial for Tracheal Intubation of the NEOnate multicenter, double-blind, randomized controlled trial of atropine-propofol vs atropine-atracurium-sufentanil for premedication before nonemergency intubation. At 2 years of corrected age, there was no significant difference between the groups in death or risk of neurodevelopmental delay assessed with the Ages and Stages Questionnaire.Trial registration Clinicaltrials.gov: NCT01490580.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Manon Tauzin, Laetitia Marchand-Martin, C écile Lebeaux, Sophie Breinig, Olivier Claris, Pierre Tourneux, Cénéric Alexandre, Corinne Levy, Camille Jung, Agnès Dechartres, Xavier Durrmeyer, PREmedication Trial for Tracheal Intubation of the NEOnate Res Tags: Brief Reports Source Type: research
More News: Brain | Clinical Trials | Diprivan | Neurology | Pediatrics | Perinatology & Neonatology | Propofol | Study